| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | LOPEZ SOTO, ALFONSO |
| dc.contributor.author | Fernández-Moyano, Antonio |
| dc.contributor.author | Barbé Gil-Ortega, José |
| dc.contributor.author | San-José, Antonio |
| dc.contributor.author | Agustí, Antònia |
| dc.contributor.author | Vidal, Xavier |
| dc.contributor.author | Formiga, Francesc |
| dc.date.accessioned | 2025-01-27T11:26:05Z |
| dc.date.available | 2025-01-27T11:26:05Z |
| dc.date.issued | 2014-10 |
| dc.identifier.citation | San-José A, Agustí A, Vidal X, Formiga F, López-Soto A, Fernández-Moyano A, et al. Inappropriate prescribing to older patients admitted to hospital: A comparison of different tools of misprescribing and underprescribing. Eur J Intern Med. 2014 Oct;25(8):710–6. |
| dc.identifier.issn | 1879-0828 |
| dc.identifier.uri | https://hdl.handle.net/11351/12495 |
| dc.description | Inappropriate prescribing; Older multimorbidity patients; Potentially prescribing omissions |
| dc.description.abstract | Purpose
This study aims to assess inappropriate prescribing (IP) to elderly patients during the month prior to hospitalization and to compare different IP criteria.
Methods
An observational, prospective and multicentric study was carried out in the internal medicine services of seven Spanish hospitals. Patients aged 75 years and older were randomly selected after hospital admission for a year. To assess potentially inappropriate medicines (PIMs), the Beers and STOPP criteria were used and to assess potentially prescribing omissions (PPOs), the START criteria and ACOVE-3 medicine quality indicators were used. An analysis to assess factors associated with IP was performed.
Results
672 patients [median age (Q1–Q3) 82 (79–86) years, 55.9% female] were included. Median prescribed medicines in the month prior to hospitalization were 10(Q1–Q3 7–13). The prevalence of IP was 87.6%, and 54.3% of patients had PIMs and PPOs concurrently. A higher prevalence rate of PIMs was predicted using the STOPP criteria than with the Beers criteria (p < 0.001) and a higher prevalence of PPOs using the ACOVE-3 criteria than using the START criteria (p < 0.001) was observed. Polypharmacy (≥ 10 medicines) was the strongest predictor of IP [OR = 11.34 95% confidence interval (CI) 4.96–25.94], PIMs [OR = 14.16, 95% CI 6.44–31.12], Beers-listed PIMs [OR = 8.19, 95% CI 3.01–22.28] and STOPP-listed PIMs [OR = 8.21, 95% CI 3.47–19.44]. PIMs was the strongest predictor of PPOs [OR = 2.79, 95% CI 1.81–4.28].
Conclusions
A high prevalence of polypharmacy and PIMs and PPOs were reported. More than half the patients had simultaneous PIMs and PPOs. The related factors to PIMs and PPOs were different. |
| dc.language.iso | eng |
| dc.publisher | Elsevier |
| dc.relation.ispartofseries | European Journal of Internal Medicine;25(8) |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.source | Scientia |
| dc.subject | Hospitals - Ingressos i altes |
| dc.subject | Persones grans |
| dc.subject | Errors de medicació |
| dc.subject.mesh | Inappropriate Prescribing |
| dc.subject.mesh | Medication Errors |
| dc.subject.mesh | Aged |
| dc.subject.mesh | Polypharmacy |
| dc.subject.mesh | Hospitalization |
| dc.title | Inappropriate prescribing to older patients admitted to hospital: A comparison of different tools of misprescribing and underprescribing |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1016/j.ejim.2014.07.011 |
| dc.subject.decs | prescripción inadecuada |
| dc.subject.decs | errores de medicación |
| dc.subject.decs | anciano |
| dc.subject.decs | polimedicación |
| dc.subject.decs | hospitalización |
| dc.relation.publishversion | https://doi.org/10.1016/j.ejim.2014.07.011 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [San-José A, Barbé J] Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Multimorbidity and Elderly Patients Group of the Spanish Society of Internal Medicine, Spain. [Agustí A, Vidal X] Servei de Farmacologia Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Fundació Institut Català de Farmacologia, Barcelona, Spain. Departament de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Formiga F] Internal Medicine Service, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain. Multimorbidity and Elderly Patients Group of the Spanish Society of Internal Medicine, Spain. [López-Soto A] Internal Medicine Service, Hospital Clínic, Barcelona, Spain. Multimorbidity and Elderly Patients Group of the Spanish Society of Internal Medicine, Spain. [Fernández-Moyano A] Internal Medicine Service, Hospital San Juan De Dios del Aljarafe, Sevilla, Spain. Multimorbidity and Elderly Patients Group of the Spanish Society of Internal Medicine, Spain |
| dc.identifier.pmid | 25179678 |
| dc.identifier.wos | 000343807000012 |
| dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess |